Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Finasteride helped treat a 28-year-old's facial skin condition.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Facial hidradenitis suppurativa can be mistaken for acne but requires different treatment.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Finasteride improved hidradenitis suppurativa in kids without side effects.

Patients with hidradenitis suppurativa have a different skin microbiome compared to healthy people.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Hidradenitis suppurativa is a skin condition possibly caused by hair follicle issues, with treatments focusing on infection and inflammation.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Hidradenitis suppurativa improves with antiandrogen therapy.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.